This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Evaluating the Market Potential of Uplizna As A Treatment For Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Ticker(s): HZNPWho's the expert?
Institution: Medical College of Wisconsin
- Director, Division of MS/Neuro-Immunology at the Medical College of Wisconsin.
- Published over 175 abstracts and papers on the use of ingested type I interferons in humans and animal models of autoimmune disease.
Interview GoalUnderstanding the treatment options for Neuromyelitis Optica Spectrum Disorder and how Uplizna fits in the space.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
